Home > Browse Research > Life Sciences > Diagnostics > In Vitro Diagnostics > Immunoassays

Immunoassays: market research reports

An immunoassay is a diagnostic test utilizing a biochemical process that detects the presence or quantifies the concentration of a substance in solutions, such as blood, serum or urine, which frequently contain a complex mixture of substances.
An immunoassay is one of the most effectual analytical tests performed due to its specificity, sensitivity and versatility. To test the concentration of a substance within a solution, immunoassay tests use specific antibodies that will react with antigens in the solution.
Monoclonal antibodies provide accurate test results and are the most common antibodies used in immunoassay testing due to their ability to bind to one site of any particular molecule. To get an accurate result, the specific antibody must have a high affinity to the antigen being tested for. The number of antigens and antibodies present in the tested solution is measured. This measurement tells how much of the analyte is located within the sample and how concentrated it is.
One of the most widely used immunoassay applications for the detection of infectious disease is the enzyme-linked immunosorbant assay (ELISA). Because of its high sensitivity, the ELISA was the first screening test widely used for HIV.
Immunoassays are significant tests that perform an array of functions in conventional medicine. While it is used primarily to test for things such as HIV in the body, the test can also be used to discover new ways to test for other diseases and conditions that don’t have a direct scientific diagnostic method.

Immunoassays market research reports and industry analysis

Global Markets and Technologies for Cell and Tissue Analysis - Focus on Biospecimen Preparation 1/1/2013 \| published by: BCC Research ... may be commercially viable in the next few years; this report focuses on biospecimen preparation Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) ... \| more...	$3,900.00
Global Markets and Technologies for Cell and Tissue Analysis - Focus on Cell and Tissue Separation 1/1/2013 \| published by: BCC Research ... may be commercially viable in the next few years; this report focuses on cell and tissue separation Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth ... \| more...	$3,900.00
Global Markets and Technologies for Cell and Tissue Analysis - Focus on Cell and Tissue Characterization 1/1/2013 \| published by: BCC Research ... may be commercially viable in the next few years; this report focuses on cell and tissue characterization Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth ... \| more...	$3,900.00
Global Markets and Technologies for Cell and Tissue Analysis 1/1/2013 \| published by: BCC Research ... may be commercially viable in the next few years. Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017. Detailed discussion of biospecimens, ... \| more...	$4,850.00
Innovative H. Pylori Diagnostic Technologies and Emerging Markets 11/30/2012 \| published by: Venture Planning Group ... Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Physician Offices - Commercial/Private Labs ... \| more...	$3,850.00
Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends 11/26/2012 \| published by: Frost & Sullivan ... technology. The research strives to compare differences of current and future use between qPCR and dPCR; identify dPCR and dPCR technology brand use and future use trends; evaluate currently used qPCR and dPCR technology brands; ... \| more...	$10,000.00
Analysis of Tumor Marker Testing Instrumentation And Strategic Profiles of Leading Suppliers 9/27/2012 \| published by: Venture Planning Group ... diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 119 pages Please note : The delivery time for the electronic version of this ... \| more...	$3,500.00
Analysis of Transfusion Diagnostic Instrumentation And Strategic Profiles of Leading Suppliers 9/27/2012 \| published by: Venture Planning Group ... sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 68 pages Please note : The delivery time for the electronic version of this report is between 1-3 ... \| more...	$3,500.00
Analysis of Transfusion Diagnostic Technologies And Strategic Profiles of Leading Suppliers 9/27/2012 \| published by: Venture Planning Group ... potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, ... \| more...	$3,500.00
Analysis of Tumor Markers Technologies And Strategic Profiles of Leading Suppliers 9/27/2012 \| published by: Venture Planning Group ... of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, ... \| more...	$3,500.00
Analysis of Emerging Tumor Markers and Strategic Profiles of Leading Suppliers 9/21/2012 \| published by: Venture Planning Group ... Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and ... \| more...	$3,500.00
Analysis of Transfusion Diagnostic Typing, Grouping and Screening Tests, And Strategic Profiles and Leading Suppliers 9/21/2012 \| published by: Venture Planning Group ... developing or marketing innovative blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, ... \| more...	$3,500.00
Analysis of Emerging Immunodiagnostic Tests And Strategic Profiles of Leading Suppliers 9/21/2012 \| published by: Venture Planning Group ... The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and ... \| more...	$3,950.00
Future Horizons in the Global Chancroid Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country 8/30/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume ... \| more...	$3,850.00
Future Horizons in the Global Hepatitis Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country 8/30/2012 \| published by: Venture Planning Group ... report provides the 5- and 10-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in ... \| more...	$8,750.00
Future Horizons in the French Transfusion Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment 8/28/2012 \| published by: Venture Planning Group ... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in French transfusion testing hospitals, and commercial laboratories. Annual placements ... \| more...	$5,400.00
Future Horizons in the German Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment 8/28/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| more...	$5,400.00
Future Horizons in the Germany Transfusion Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment 8/28/2012 \| published by: Venture Planning Group ... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in German transfusion testing hospitals, and commercial laboratories. Annual placements ... \| more...	$5,400.00
Future Horizons in the Global Transfusion Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Country 8/28/2012 \| published by: Venture Planning Group ... and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments ... \| more...	$38,600.00
Future Horizons in the Italian Transfusion Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment 8/28/2012 \| published by: Venture Planning Group ... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Italian transfusion testing hospitals, and commercial laboratories. Annual placements ... \| more...	$5,400.00
Future Horizons in the Italian Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment 8/28/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| more...	$5,400.00
Future Horizons in the Japanese Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment 8/28/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| more...	$6,700.00
Future Horizons in the Spanish Transfusion Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment 8/28/2012 \| published by: Venture Planning Group ... impact during the next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Spanish transfusion testing hospitals, and commercial laboratories. Annual placements ... \| more...	$5,400.00
Future Horizons in the US Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment 8/28/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| more...	$8,700.00
Future Horizons in the French Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment 8/28/2012 \| published by: Venture Planning Group ... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ... \| more...	$5,400.00

< prev 1 2 3 4 5 next >

Research assistance

Matching geography

Start new browse

Join Alert Me now!

Immunoassays: market research reports

Immunoassays market research reports and industry analysis